Armed with more than 20 years of experience in sales and marketing, Larry Chen, formerly director, Asia Pacific at Zipline Medical, Inc., has been named Managing Director, China and Asia Pacific for Bioventus Inc. Chen, whose prior roles were at health care companies with a presence in the region, will be based in Shenzhen, China.
“We are glad to welcome Larry to Bioventus and look forward to leveraging his experience and relationships in both China, as we explore our expansion opportunities there, and throughout the Asia Pacific region,” said John Nosenzo, Chief Commercial Officer, Bioventus. “We believe patients and clinicians will benefit greatly from our solutions in osteoarthritic joint pain, minimally invasive trauma and bone graft substitutes.”
Chen spent four years at Zipline Medical as director, Asia Pacific, until the company was acquired by Stryker Corporation. Previously, Chen was sales director, and later marketing director, Greater China, for Smith & Nephew; he also spent time at ArthoCare Corporation where he served in regional sales and marketing roles.
His work experience also includes Asia Pacific regional commercial leadership roles at Johnson & Johnson Medical/Ethicon, Mentor Corp. and Stryker. Chen’s initial work experience was as an export sales manager at China Qing ’An International Trading in Beijing.
Chen earned an MBA from the University of Leuven and a Bachelor of Science in Economics from the University of International Business and Economics in Beijing.
Chen told OTW, “It is exciting to be a part of Bioventus as the company puts more focus on Asia, especially China, and to have the opportunity to plan and actively relaunch our products in markets within Asia where we have a presence. In addition, I look forward to identifying new market for our products.”
As for how will proceed initially, Chen commented to OTW, “I will assess current coverage, representation and engagement of our distribution partners, visit markets to speak with customers and look to identify best practices across regions and segments, both in and outside of the company.”
